未登录

B

Berith Nilsson

Uppsala University

H指数:10

被引数:672

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safe engineering of CAR T cells for adoptive cell therapy of cancer using long-term episomal gene transfer

EMBO MOLECULAR MEDICINE

IF8.3

2016-05-0661

OAAI

TARP-TCR-engineered T cells specifically kill HLA-A2 positive prostate and breast cancer cells.

CANCER RESEARCH

IF16.6

2014-04-020

PRE

T cells engineered with a T cell receptor against the prostate antigen TARP specifically kill HLA-A2+ prostate and breast cancer cells

用针对前列腺抗原TARP的T细胞受体改造的T细胞特异性杀死HLA-A2前列腺癌和乳腺癌细胞

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2012-09-1033

OAAI

CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery

CAR/FoxP3-engineered T调节细胞靶向CNS并在鼻内递送后抑制EAE

JOURNAL OF NEUROINFLAMMATION

IF10.1

2012-05-30300

OAAI

Adenovirus with Hexon Tat-Protein Transduction Domain Modification Exhibits Increased Therapeutic Effect in Experimental Neuroblastoma and Neuroendocrine Tumors

JOURNAL OF VIROLOGY

IF3.8

2011-12-1538

OAAI

Increased Therapeutic Efficacy of the Prostate-Specific Oncolytic Adenovirus Ad[I/PPT-E1A] by Introduction of the Entire E3 Region or the Adenovirus Death Protein

MOLECULAR THERAPY

IF12

2006-01-010

OAAI

Simultaneous generation of cytomegalovirus-specific CD8+ and CD4+ T lymphocytes by use of dendritic cells comodified with pp65 mRNA and pp65 protein

JOURNAL OF INFECTIOUS DISEASES

IF4.5

2005-12-016

PREAI

A novel TARP-promoter-based adenovirus against hormone-dependent and hormone-refractory prostate cancer

MOLECULAR THERAPY

IF12

2004-08-0142

OAAI